Annegret Preuss

Title: Annegret Preuss: Innovator in Nanoparticle Carrier Systems

Introduction

Annegret Preuss is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of nanoparticle carrier systems for photodynamic therapy. Her innovative work focuses on enhancing the efficacy and safety of photosensitizers used in medical treatments.

Latest Patents

Annegret Preuss holds a patent for "Nanoparticle carrier systems based on human serum albumin for photodynamic therapy." This patent describes compositions that are stable in storage and a method for producing pharmaceutical-based nanoparticulate formulations. These formulations include a hydrophobic photosensitizer, human serum albumin (HSA), and a stabilizing agent. The nanoparticulate formulations provide therapeutically effective amounts of photosensitizer for parenteral administration. Notably, tetrapyrrole derivatives can be utilized as photosensitizers, with their efficacy and safety enhanced by these formulations. The patent also outlines a method for preparing HSA-based nanoparticles under sterile conditions, with a preferred embodiment involving temoporfin as a hydrophobic photosensitizer for treating hyperplastic and neoplastic conditions, particularly targeting tumor cells.

Career Highlights

Throughout her career, Annegret Preuss has worked with notable companies such as Biolitec Pharma Marketing Ltd and Biolitec Holding GmbH & Co. KG. Her experience in these organizations has contributed to her expertise in the development of innovative pharmaceutical solutions.

Collaborations

Annegret has collaborated with esteemed colleagues, including Klaus Langer and Matthias Wacker, further enhancing her research and development efforts in the field of nanoparticle technology.

Conclusion

Annegret Preuss is a trailblazer in the realm of nanoparticle carrier systems, with her patent and career achievements reflecting her dedication to advancing medical therapies. Her work continues to impact the field of photodynamic therapy positively.